Annual long term liabilities:
$227.00M+$176.85M(+352.66%)Summary
- As of today (May 24, 2025), VRNA annual total long term liabilities is $227.00 million, with the most recent change of +$176.85 million (+352.66%) on December 31, 2024.
- During the last 3 years, VRNA annual long term liabilities has risen by +$221.84 million (+4299.26%).
- VRNA annual long term liabilities is now at all-time high.
Performance
VRNA Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$242.80M+$15.79M(+6.96%)Summary
- As of today (May 24, 2025), VRNA quarterly total long term liabilities is $242.80 million, with the most recent change of +$15.79 million (+6.96%) on March 31, 2025.
- Over the past year, VRNA quarterly long term liabilities has increased by +$192.65 million (+384.14%).
- VRNA quarterly long term liabilities is now at all-time high.
Performance
VRNA quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
VRNA Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +352.7% | +384.1% |
3 y3 years | +4299.3% | +4656.1% |
5 y5 years | +10000.0% | +9645.8% |
VRNA Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +4299.3% | at high | +4656.1% |
5 y | 5-year | at high | >+9999.0% | at high | +9645.8% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
VRNA Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $242.80M(+7.0%) |
Dec 2024 | $227.00M(+352.7%) | $227.00M(+1.6%) |
Sep 2024 | - | $223.38M(+2.7%) |
Jun 2024 | - | $217.50M(+333.7%) |
Mar 2024 | - | $50.15M(+0.0%) |
Dec 2023 | $50.15M(+402.8%) | $50.15M(+151.7%) |
Sep 2023 | - | $19.93M(+0.2%) |
Jun 2023 | - | $19.89M(+0.1%) |
Mar 2023 | - | $19.87M(+99.3%) |
Dec 2022 | $9.97M(+93.3%) | $9.97M(+89.6%) |
Sep 2022 | - | $5.26M(+2.9%) |
Jun 2022 | - | $5.11M(+0.2%) |
Mar 2022 | - | $5.11M(-1.1%) |
Dec 2021 | $5.16M(+0.2%) | $5.16M(-8.2%) |
Sep 2021 | - | $5.62M(-2.1%) |
Jun 2021 | - | $5.74M(+14.0%) |
Mar 2021 | - | $5.04M(-2.2%) |
Dec 2020 | $5.15M(+689.7%) | $5.15M(-83.5%) |
Sep 2020 | - | $31.25M(+3.1%) |
Jun 2020 | - | $30.31M(+1116.5%) |
Mar 2020 | - | $2.49M(+282.1%) |
Dec 2019 | $652.00K(-53.4%) | $652.00K(-70.7%) |
Sep 2019 | - | $2.22M(+54.0%) |
Jun 2019 | - | $1.44M(-0.6%) |
Mar 2019 | - | $1.45M(+3.8%) |
Dec 2018 | $1.40M | $1.40M(-0.6%) |
Sep 2018 | - | $1.41M(+1.4%) |
Jun 2018 | - | $1.39M(-3.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $1.44M(+4.0%) |
Dec 2017 | $1.39M(+40.3%) | $1.39M(+21.6%) |
Sep 2017 | - | $1.14M(+5.0%) |
Jun 2017 | - | $1.09M(+9.9%) |
Dec 2016 | $989.50K(+12.5%) | $989.50K(>+9900.0%) |
Jun 2016 | - | $0.00(-100.0%) |
Dec 2015 | $879.90K(>+9900.0%) | $879.90K(>+9900.0%) |
Jun 2015 | - | $0.00(0.0%) |
Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2012 | - | $0.00(0.0%) |
Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2011 | - | $0.00(0.0%) |
Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2010 | - | $0.00(0.0%) |
Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2008 | - | $0.00(0.0%) |
Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2007 | - | $0.00(0.0%) |
Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
Jun 2006 | - | $0.00(0.0%) |
Dec 2005 | $0.00 | $0.00(0.0%) |
Jun 2005 | - | $0.00 |
FAQ
- What is Verona Pharma annual total long term liabilities?
- What is the all time high annual long term liabilities for Verona Pharma?
- What is Verona Pharma annual long term liabilities year-on-year change?
- What is Verona Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Verona Pharma?
- What is Verona Pharma quarterly long term liabilities year-on-year change?
What is Verona Pharma annual total long term liabilities?
The current annual long term liabilities of VRNA is $227.00M
What is the all time high annual long term liabilities for Verona Pharma?
Verona Pharma all-time high annual total long term liabilities is $227.00M
What is Verona Pharma annual long term liabilities year-on-year change?
Over the past year, VRNA annual total long term liabilities has changed by +$176.85M (+352.66%)
What is Verona Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of VRNA is $242.80M
What is the all time high quarterly long term liabilities for Verona Pharma?
Verona Pharma all-time high quarterly total long term liabilities is $242.80M
What is Verona Pharma quarterly long term liabilities year-on-year change?
Over the past year, VRNA quarterly total long term liabilities has changed by +$192.65M (+384.14%)